Dr. reddy's laboratories announces the launch of fluphenazine hydrochloride tablets, usp in the u.s. market

Hyderabad, india & princeton, n.j.--(business wire)--dr. reddy's laboratories ltd. (bse: 500124, nse: drreddy, nyse: rdy, nseifsc: drreddy along with its subsidiaries together referred to as “dr. reddy's”) today announced the launch of fluphenazine hydrochloride tablets, usp, a therapeutic equivalent generic version of prolixin tablets, 1 mg, 2.5 mg, 5 mg, and 10 mg, approved by the u.s. food and drug administration (usfda). the prolixin brand and generic had u.s. sales of approximately $134 mi
RDY Ratings Summary
RDY Quant Ranking